- Home
- MDT vs NTES Comparison
MDT vs NTES Comparison
Compare MDT & NTES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDT
- NTES
- Stock Information
- Founded
- MDT 1949
- NTES 1997
- Country
- MDT Ireland
- NTES China
- Employees
- MDT N/A
- NTES N/A
- Industry
- MDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- NTES Computer Software: Prepackaged Software
- Sector
- MDT Health Care
- NTES Technology
- Exchange
- MDT Nasdaq
- NTES Nasdaq
- Market Cap
- MDT 114.9B
- NTES 95.1B
- IPO Year
- MDT N/A
- NTES 2000
- Fundamental
- Price
- MDT $96.64
- NTES $137.96
- Analyst Decision
- MDT Buy
- NTES Strong Buy
- Analyst Count
- MDT 17
- NTES 6
- Target Price
- MDT $103.80
- NTES $129.83
- AVG Volume (30 Days)
- MDT 6.3M
- NTES 644.1K
- Earning Date
- MDT 11-18-2025
- NTES 11-20-2025
- Dividend Yield
- MDT 2.95%
- NTES 2.10%
- EPS Growth
- MDT 21.95
- NTES 19.96
- EPS
- MDT 3.62
- NTES 1.49
- Revenue
- MDT $34,200,000,000.00
- NTES $15,310,016,889.00
- Revenue This Year
- MDT $7.97
- NTES $11.57
- Revenue Next Year
- MDT $5.47
- NTES $7.73
- P/E Ratio
- MDT $26.59
- NTES $92.72
- Revenue Growth
- MDT 4.98
- NTES 2.75
- 52 Week Low
- MDT $79.29
- NTES $84.97
- 52 Week High
- MDT $99.37
- NTES $159.55
- Technical
- Relative Strength Index (RSI)
- MDT 64.10
- NTES 38.66
- Support Level
- MDT $94.64
- NTES $137.93
- Resistance Level
- MDT $96.71
- NTES $143.59
- Average True Range (ATR)
- MDT 1.50
- NTES 2.30
- MACD
- MDT 0.64
- NTES -0.11
- Stochastic Oscillator
- MDT 93.30
- NTES 2.62
About MDT Medtronic plc.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
About NTES NetEase Inc.
Founded in the late 1990s as an internet portal, NetEase has transformed into a leading force in the second-largest online game company gaming in China. While its initial success was built upon the massively multiplayer online role-playing game Fantasy Westward Journey, NetEase has expanded its portfolio with captivating franchises that resonate with both domestic and international players. Over the past decade, the company has created titles such as Justice, Identity V, Naraka: Bladepoint, and Eggy Party, all of which maintain significant player bases today. Beyond in-house development, the company also collaborates with likes of Microsoft and Marvel to create and publish games based on renowned IPs, including World of Warcraft, Diablo Immortal, and Marvel Rivals.